Eiger BioPharmaceuticals, Inc. EIGRQ

8.50 0.00 0.00% as of 1 Oct
Market cap
$2.6M
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Mar '23 Jun '23 Sep '23 Dec '23
Cash and Short Term Investments

+8 more quarters

75.27 53.61 39.42 25.44
Receivables
3.89 3.72 1.32 1.68
Inventory
5.34 1.10 1.11 1.56
Total current assets
96.91 70.48 54.62 37.84
Property, Plant, Equpment (Net)
0.80 0.76 0.68 0.63
Long-term assets (Other)
1.07 0.79 0.14 0.36
Total non-current assets
2.32 1.87 1.03 0.99
Total Assets
99.23 72.36 55.65 38.83
Accounts Payable
11.86 4.95 4.86 2.12
Accrued Expenses
11.71 11.45 11.46 9.97
Current Part of Debt
0.44 0.32 0.21 41.12
Total current liabilities
24.00 16.71 16.52 53.28
Long Term Debt (Total)
39.99 40.35 40.73 —
Total non-current liabilities
39.99 40.35 40.73 —
Total liabilities
63.99 57.06 57.26 53.28
Additional Paid In Capital
495.34 496.09 497.14 497.87
Common Stock (Net)
0.04 0.04 0.04 0.00
Retained Earnings
(459.98) (480.67) (498.70) (512.16)
Common Equity (Total)
35.24 15.30 (1.60) (14.46)
Shareholders Equity (Total)
35.24 15.30 (1.60) (14.46)
Shareholders Equity and Liabilities (Total)
99.23 72.36 55.65 38.83
Shares (Common)
1.48 1.48 1.48 1.48
Shareholders Equity (Tangible)
35.24 15.30 (1.60) (14.46)
Net Debt
(34.85) (12.94) 1.52 15.68
Total Debt
40.42 40.67 40.94 41.12

Fold the line items

In millions of $ except per-share values · columns are period end dates